Company: CERO
Filing Date: 2025-04-28
Form Type: 10-K/A
Source: 0001213900-25-036075
Chunk: 39

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-28
Form: 10-K/A
Chunk 39
---
     |              |    * |   |
| Lindsey Rolfe, M.D.(9)                                                      |     |              |   5,976 |     |              |    * |   |
| Shami Patel(10)                                                             |     |              |   5,040 |     |              |    * |   |
| All current directors and executive officers as a group (eight individuals) |     |              | 657,137 |     |              | 12.2 | % |

| * | Represents beneficial ownership of less than 1% of our outstanding 
 Common Stock.                                                      |

| (1) | Unless otherwise noted, the business address of each of the                         
 following individuals is 210 Haskins Way, Suite 230, South San Francisco, CA 94080. |

| (2) | Consists of (i) 7,813 shares of Common Stock issuable on                                                                           
 the conversion of shares of Series A Preferred Stock, (ii) 90,206 shares of Common Stock issuable on the conversion of shares      
 of Series C Preferred Stock, (iii) 1,532 shares of Common Stock issuable on the exercise of Series A Warrants, and (v) 187,200     
 shares of Common Stock issuable on the exercise of Series C Warrants. The principal business address of Funicular Funds, LP is 601 
 California Street, Suite 1151, San Francisco, CA 94108-2816.                                                                       |

20

| (3) | Consists of (i) 57,919 shares of Common Stock, (ii) 50                                                                          
 shares of Common Stock issuable upon the exercise of Warrants exercisable within 60 days of April 11, 2025, (iii) 53,721 shares 
 of Common Stock issuable pursuant to stock options exercisable within 60 days of April 11, 2025, and (iv) 36 shares of Common   
 Stock held by his spouse, Sara Fried.                                                                                           |

| (4) | Consists of 2,500 shares of Common Stock, issuable pursuant    
 to stock options exercisable within 60 days of April 11, 2025. |

| (5) | Consists of 1,500 shares of Common Stock issuable pursuant to 
 stock options exercisable within 60 days of April 11, 2025.   |

| (6) | Consists of (i) 1,250